HuGE Literature Finder
Records
1
-
3
A new parameter in multiple myeloma: CYP3A4*1B single nucleotide polymorphism. Annals of hematology 2020 Nov . Serin Istemi, Pehlivan Sacide, Gundes Ilknur, Fidan Oyaci Yasemin, Pehlivan Musta |
Effect of CYP2C19 and CYP3A4 gene polymorphisms on the efficacy of bortezomib-based regimens in patients with multiple myeloma. Oncology letters 2015 Aug 10 (2): 1171-1175. Zhou Weiwei, An Guangyu, Jian Yuan, Guo Huan, Chen Wenmi |
Influence of genetic polymorphisms in CYP3A4, CYP3A5, GSTP1, GSTM1, GSTT1 and MDR1 genes on survival and therapy-related toxicity in multiple myeloma. Haematologica 2007 Feb 92 (2): 277-8. Schilthuizen Céline, Broyl Annemiek, van der Holt Bronno, de Knegt Yvonne, Lokhorst Henk, Sonneveld Piet |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 31, 2023
- Content source: